Global Latanoprost Market Analysis 2011-2017 and Forecast 2018-2023
Snapshot
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
The global Latanoprost market will reach Volume Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Latanoprost by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Brand Drug
Generic Drug
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Open-angle Glaucoma
Close-angle Glaucoma
Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
The global Latanoprost market will reach Volume Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Latanoprost by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Brand Drug
Generic Drug
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Open-angle Glaucoma
Close-angle Glaucoma
Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
